Morning Briefing: Major World Equities Market Indexes
$DIA, $DAX, $DJSH, $N300, $NSEI
Commentary: Global stocks do not look very strong in here, as they could see rejections from resistances above current marks, consolidation is preferred in here. PE
Notes: The S&P 500 advanced 0.3% Friday, posting a weekly gainer of 0.6%, helped by a report that Chinese and US negotiators are planning talks to try to end their trade disagreement ahead of multilateral meetings between US President Trump and President Xi in November. The DIA added 0.4% Friday, the NAS Comp + 0.1%.
Friday’s gains were broad-based, with all 11 S&P sectors closing in the Green. The industrials (+0.6%), materials (+0.7%), consumer staples (+0.7%), and real estate (+1.0%) sectors were the top performers, while consumer discretionary (+0.1%), financials (+0.2%), and technology (+0.2%) finished at the back of the pack.
In Asia Monday
DJIA at 25669.32, +0.43% moved up to again test 1st resistance at 25750. If the resistance holds, a fall back to 25500 is possible, or else a run above 25750 signals Bullishness to 26000-26800 medium term.
DAX at 12210.55, -0.22%, and while it trades below 12300 it can test to 12000.
Nikkei at 22226.45, -0.20% is trading higher after bouncing from 21850. Range trade within 22800-21850 seen for a few weeks. A break on either side is needed to confirm Nikkei’s direction.
Shanghai at 2680.87, +0.45% looks weak, 1st support is seen at 2650. Overall weakness is visible now and for the foreseeable future. Range trade within 2750-2650 could continue through this week.
Nifty at 11470.75, +0.75% seeing resistance at 11,500. A clear break above that mark may bring on a rise to 11600-11800 medium term; a fall from here could lead to some consolidation under 11500, then a fall to 11300-11200.
Have a terrific week
Latest posts by Paul Ebeling (see all)
- The Street’s Key Stock Analysts Research Reports - September 18, 2018
- Wrecked Your Tesla? (NASDAQ:TSLA) CEO Musk Wants to Fix it ‘In House’ - September 18, 2018
- Curcumin Joins an Elite Group in Clinical Trials for Cancer Prevention - September 18, 2018